SINGAPORE (Jan 28): Singapore eDevelopment announced that its US biomedical subsidiary, Global BioLife, has a product – 3F Antimicrobial Fragrance – that shows efficacy against tuberculosis.

Tuberculosis has caused more than 1.6 million deaths worldwide and infected over 10 million people in 2017, placing it in among the top 10 leading causes of deaths globally, according to the World Health Organisation.

Global BioLife’s 3F Antimicrobial Fragrance is shown to inhibit Mycobacterium tuberculosis (MTB), the causative bacterial agent of tuberculosis.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook